 |
|
Community-Acquired Methicillin-Resistant Staphylococcus aureus—Reply
|
|
| Since this article does not have an abstract, we have provided the first 150 words of the full text and any section headings. |
|
|
|
In Reply: In response to Drs Salgado and Farr, we acknowledged that conducting sentinel site rather than population-based surveillance for MRSA infection was a limitation of our study. The primary advantage of a population-based study would be to determine population-based incidence rates reflecting all patient encounters. However, our sentinel approach demonstrated considerable differences between health care–associated and community-associated MRSA, and represents the most comprehensive study of its type published to date.
We agree that obtaining data on community-associated MRSA prevalence (ie, colonization) will be an important step in understanding the evolving epidemiology of MRSA. We are considering such a study of colonization prevalence. We will be conducting a population-based invasive MRSA surveillance study in a Minnesota county as part of the Center for Disease Control and Prevention's Active Bacterial Core Surveillance program. Studies like these will be important as hospitals consider the recommendation from the Society for Healthcare Epidemiology of . . . [Full Text of this Article]
Kathleen LeDell, MPH, RN;
Timothy Naimi, MD, MPH;
Scott Fridkin, MD;
Ruth Lynfield, MD
Centers for Disease Control and Prevention
Atlanta, Ga
RELATED ARTICLES
Community-Acquired Methicillin-Resistant Staphylococcus aureus
Cassandra D. Salgado and Barry M. Farr
JAMA. 2004;291(16):1960-1961.
EXTRACT
| FULL TEXT
Comparison of Community- and Health Care–Associated Methicillin-Resistant Staphylococcus aureus Infection
Timothy S. Naimi, Kathleen H. LeDell, Kathryn Como-Sabetti, Stephanie M. Borchardt, David J. Boxrud, Jerome Etienne, Susan K. Johnson, Francois Vandenesch, Scott Fridkin, Carol O'Boyle, Richard N. Danila, and Ruth Lynfield
JAMA. 2003;290(22):2976-2984.
ABSTRACT
| FULL TEXT
|
